Wenbin Xiao

机构：Memorial Sloan Kettering Cancer Center · ORCID：0000-0001-8586-8500

发表论文 224 篇 · 总被引 12282 次 · h-index 35

代表论文

• In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy (2024 · Cancer Cell · 被引 12)
• CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis (2025 · Blood · 被引 10)
• Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype (2025 · Blood · 被引 10)
• Transcriptional activation of regenerative hematopoiesis via microenvironmental sensing (2025 · Nature Immunology · 被引 7)
• Overcoming MEN1-mediated resistance with menin inhibitor switching in KMT2A-rearranged acute myeloid leukemia (2026 · Leukemia · 被引 6)
• Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML (2025 · Journal of Hematology & Oncology · 被引 6)